PGD for fragile X syndrome: Ovarian function is the main determinant of success

Human Reproduction

Volumn 25, Issue 10, 2010, Pages 2629-2636

  Tsafrir, Avi ^a   Altarescu, Gheona ^a   Margalioth, Ehud ^a   Brooks, Baruch ^a   Renbaum, Paul ^a   Levy Lahad, Ephrat ^a   Rabinowitz, Ron ^a   Varshaver, Irit ^a   Eldar Geva, Talia ^a  

^a HEBREW UNIVERSITY   (Israel)

Author keywords

fragile X syndrome; IVF; ovarian function; PGD; trinucleotide repeats

Indexed keywords

ESTRADIOL; GONADOTROPIN;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; EMBRYO; ESTRADIOL BLOOD LEVEL; FEMALE; FRAGILE X SYNDROME; GENE MUTATION; GENETIC DISORDER; GENETIC SCREENING; HORMONE DETERMINATION; HUMAN; LIVE BIRTH; MULTIPLEX POLYMERASE CHAIN REACTION; OOCYTE; OVARY FUNCTION; PREGNANCY OUTCOME; PREIMPLANTATION GENETIC DIAGNOSIS;

EID: 77956928337     PISSN: 02681161     EISSN: 14602350     Source Type: Journal    
DOI: 10.1093/humrep/deq203     Document Type: Article

References (41)

1. ACOG Committee Opinion. No.338: screening for fragile X syndrome. Obstet Gynecol 2006;107:1483-1485.
2. Allen EG, Sullivan AK, Marcus M, Small C, Dominguez C, Epstein MP, Charen K, He W, Taylor KC, Sherman SL. Examination of reproductive aging milestones among women who carry the FMR1 premutation. Hum Reprod 2007;22:2142-2152.
3. Altarescu G, Brooks B, Kaplan Y, Eldar-Geva T, Margalioth EJ, Levy-Lahad E, Renbaum P. Single-sperm analysis for haplotype construction of de-novo paternal mutations: application to PGD for neurofibromatosis type 1. Hum Reprod 2006;21:2047-2051.
4. Altarescu G, Renbaum P, Brooks PB, Margalioth EJ, Ben Chetrit A, Munter G, Levy-Lahad E, Eldar-Geva T. Successful polar body-based preimplantation genetic diagnosis for achondroplasia. Reprod Biomed Online 2008a;6:276-282.
5. Altarescu G, Brooks B, Eldar-Geva T, Margalioth EJ, Singer A, Levy-Lahad E, Renbaum P. Polar body-based preimplantation genetic diagnosis for N-acetylglutamate synthase deficiency. Fetal Diagn Ther 2008b;24:170-176.
6. Altarescu G, Eldar-Geva T, Varshower I, Brooks B, Haran EZ, Margalioth EJ, Levy-Lahad E, Renbaum P. Real-time reverse linkage using polar body analysis for preimplantation genetic diagnosis in female carriers of de novo mutations. Hum Reprod 2009;24:3225-3229.
7. Apessos A, Abou-Sleiman PM, Harper JC, Delhanty JD. Preimplantation genetic diagnosis of the fragile X syndrome by use of linked polymorphic markers. Prenat Diagn 2001;21:504-511.
8. Bibi G, Malcov M, Yuval Y, Reches A, Ben-Yosef D, Almog B, Amit A, Azem F. The effect of CGG repeat number on ovarian response among fragile X premutation carriers undergoing preimplantation genetic diagnosis. Fertil Steril 2009; (28 May, epub ahead of print).
9. Burlet P, Frydman N, Gigarel N, Kerbrat V, Tachdjian G, Feyereisen E, Bonnefont JP, Frydman R, Munnich A, Steffann J. Multiple displacement amplification improves PGD for fragile X syndrome. Mol Hum Reprod 2006;12:647-652.
10. Ciotti PM, Lagalla C, Ricco AS, Fabbri R, Forabosco A, Porcu E. Micromanipulation of cryopreserved embryos and cryopreservation of micromanipulated embryos in PGD. Mol Cell Endocrinol 2000;169:63-67.
11. Ennis S, Ward D, Murray A. Nonlinear association between CGG repeat number and age of menopause in FMR1 premutation carriers. Eur J Hum Genet 2006;14:253-255.
12. Feyereisen E, Amar A, Kerbrat V, Steffann J, Munnich A, Vekemans M, Frydman R, Frydman N. Myotonic dystrophy: does It affect ovarian follicular status and responsiveness to controlled ovarian stimulatioň Hum Reprod 2006;21:175-182.
13. Jericho H, Wilton L, Gook DA, Edgar DH. A modified cryopreservation method increases the survival of human biopsied cleavage stage embryos. Hum Reprod 2003;18:568-571.
14. Jin P, Warren ST. Understanding the molecular basis of fragile X syndrome. Hum Mol Genet 2000;9:901-908.
15. Joris H, Van den Abbeel E, Vos AD, Van Steirteghem A. Reduced survival after human embryo biopsy and subsequent cryopreservation. Hum Reprod 1999;14:2833-2837.
16. Magli MC, Gianaroli L, Fortini D, Ferraretti AP, Munne S. Impact of blastomere biopsy and cryopreservation techniques on human embryo viability. Hum Reprod 1999;14:770-773.
17. Malcov M, Naiman T, Yosef DB, Carmon A, Mey-Raz N, Amit A, Vagman I, Yaron Y. Preimplantation genetic diagnosis for fragile X syndrome using multiplex nested PCR. Reprod Biomed Online 2007; 14:515-521.
18. Martin JR, Arici A. Fragile X and reproduction. Curr Opin Obstet Gynecol 2008;20:216-220.
19. Miller SA, Dykes DD, Polesky HF. A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res 1988; 16:1215.
20. Nelson LM, Covington SN, Rebar RW. An update: spontaneous premature ovarian failure is not an early menopause. Fertil Steril 2005; 83:1327-1332.
21. Oberle I, Rousseau F, Heitz D, Kretz C, Devys D, Hanauer A, Boue J, Bertheas M, Mandel J. Instability of a 550-base pair DNA segment and abnormal methylation in fragile X syndrome. Science 1991; 252:1097-1102.
22. Partington MW, Moore DY, Turner GM. Confirmation of early menopause in fragile X carriers. Am J Med Genet 1996;64:370-372.
23. Platteau P, Sermon K, Seneca S, Van Steirteghem A, Devroey P, Liebaers I. Preimplantation genetic diagnosis for fragile Xa syndrome: difficult but not impossible. Hum Reprod 2002;17:2807-2812. (Pubitemid 35350894)
24. Rechitsky S, Strom C, Verlinsky O, Amet T, Ivakhnenko V, Kukharenko V, Kuliev A, Verlinsky Y. Allele dropout in polar bodies and blastomeres. J Assist Reprod Genet 1998;15:253-257.
25. Rechitsky S, Verlinsky O, Kuliev A, Ozen RS, Masciangelo C, Lifchez A, Verlinsky Y. Preimplantation genetic diagnosis for familial dysautonomia. Reprod Biomed Online 2003;6:488-493. (Pubitemid 36849813)
26. Renbaum P, Brooks B, Kaplan Y, Eldar-Geva T, Margalioth EJ, Levy-Lahad E, Altarescu G. Advantages of multiple markers and polar body analysis in preimplantation genetic diagnosis for alagille disease. Prenat Diagn 2007;27:317-321.
27. Sermon K, Seneca S, Vanderfaeillie A, Lissens W, Joris H, Vandervorst M, Van Steirteghem A, Liebaers I. Preimplantation diagnosis for fragile X syndrome based on the detection of the non-expanded paternal and maternal CGG. Prenat Diagn 1999;19:1223-1230.
28. Sermon KD, Michiels A, Harton G, Moutou C, Repping S, Scriven PN, SenGupta S, Traeger-Synodinos J, Vesela K, Viville S et al. ESHRE PGD consortium data collection VI: cycles from January to December 2003 with pregnancy follow-up to October 2004. Hum Reprod 2007; 22:323-336.
29. Sherman S, Pletcher BA, Driscoll DA. Fragile X syndrome: diagnostic and carrier testing. Genet Med 2005;7:584-587.
30. Sullivan AK, Marcus M, Epstein MP, Allen EG, Anido AE, Paquin JJ, Yadav-Shah M, Sherman SL. Association of FMR1 repeat size with ovarian dysfunction. Hum Reprod 2005;20:402-412.
31. Tarlatzis BC, Zepiridis L, Grimbizis G, Bontis J. Clinical management of low ovarian response to stimulation for IVF: a systematic review. Hum Reprod Update 2003;9:61-76.
32. Tejada MI, Garcia-Alegria E, Bilbao A, Martinez-Bouzas C, Beristain E, Poch M, Ramos-Arroyo MA, Lopez B, Fernandez Carvajal I, Ribate MP et al. Analysis of the molecular parameters that could predict the risk of manifesting premature ovarian failure in female premutation carriers of fragile X syndrome. Menopause 2008;15:945-949.
33. te Velde ER, Pearson PL. The variability of female reproductive ageing. Hum Reprod Update 2002;8:141154.
34. Thornhill AR, McGrath JA, Eady RA, Braude PR, Handyside AH. A comparison of different lysis buffers to assess allele dropout from single cells for preimplantation genetic diagnosis. Prenat Diagn 2001; 21:490-497.
35. Thornhill AR, deDie-Smulders CE, Geraedts JP, Harper JC, Harton GL, Lavery SA, Moutou C, Robinson MD, Schmutzler AG, Scriven PN et al. ESHRE PGD consortium Best Practice Guidelines for Clinical Preimplantation Genetic Diagnosis (PGD) and Preimplantation Genetic Screening (PGS). Hum Reprod 2005;20:35-48.
36. Tomi D, Schultze-Mosgau A, Eckhold J, Schopper B, Al-Hasani S, Steglich C, Gal A, Axt-Fliedner R, Schwinger E, Diedrich K et al. First pregnancy and life after preimplantation genetic diagnosis by polar body analysis for mucopolysaccharidosis type I. Reprod Biomed Online 2006;12:215-220.
37. Verlinsky Y, Rechitsky S, Verlinsky O, Kenigsberg D,Moshella J, Ivakhnenko V, Masciangelo C, Strom C, Kuliev A. Polar body-based preimplantation diagnosis for X-linked disorders. Reprod Biomed Online 2002;4:38-42.
38. Verlinsky Y, Kuliev A. Micromanipulation and Biopsy of Polar Bodies and Blastomeres, 2nd edn. London: Taylor Francis, 2005, 15-22.
39. Visootsak J, Warren ST, Anido A, Graham JM. Fragile X syndrome: an update for the primary pediatrician. Clin Pediatr 2005;44: 371-381.
40. Wilton L, Thornhill A, Traeger-Synodinos J, Sermon KD, Harper JC. The causes of misdiagnosis and adverse outcomes in PGD. Hum Reprod 2009;24:1221-1228.
41. Wittenberger MD, Hagerman RJ, Sherman SL, McConkie-Rosell A, Welt CK, Rebar RW, Corrigan EC, Simpson JL, Nelson LM. The FMR1 premutation and reproduction. Fertil Steril 2007; 87:456-465.